FI104068B1 - Menetelmä terapeuttisesti käyttökelpoisten indolinyyli-N-hydroksiurea- ja indolinyyli-N-hydroksaamihappojohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten indolinyyli-N-hydroksiurea- ja indolinyyli-N-hydroksaamihappojohdannaisten valmistamiseksi

Info

Publication number
FI104068B1
FI104068B1 FI933307A FI933307A FI104068B1 FI 104068 B1 FI104068 B1 FI 104068B1 FI 933307 A FI933307 A FI 933307A FI 933307 A FI933307 A FI 933307A FI 104068 B1 FI104068 B1 FI 104068B1
Authority
FI
Finland
Prior art keywords
alkyl
indolinyl
aryl
halosubstituted
alkoxy
Prior art date
Application number
FI933307A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI933307A0 (fi
FI104068B (fi
FI933307A (fi
Inventor
Takafumi Ikeda
Rodney W Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI933307A0 publication Critical patent/FI933307A0/fi
Publication of FI933307A publication Critical patent/FI933307A/fi
Application granted granted Critical
Publication of FI104068B publication Critical patent/FI104068B/fi
Publication of FI104068B1 publication Critical patent/FI104068B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI933307A 1992-07-23 1993-07-22 Menetelmä terapeuttisesti käyttökelpoisten indolinyyli-N-hydroksiurea- ja indolinyyli-N-hydroksaamihappojohdannaisten valmistamiseksi FI104068B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4197242A JP2661841B2 (ja) 1992-07-23 1992-07-23 インドリン誘導体
JP19724292 1992-07-23

Publications (4)

Publication Number Publication Date
FI933307A0 FI933307A0 (fi) 1993-07-22
FI933307A FI933307A (fi) 1994-01-24
FI104068B FI104068B (fi) 1999-11-15
FI104068B1 true FI104068B1 (fi) 1999-11-15

Family

ID=16371216

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933307A FI104068B1 (fi) 1992-07-23 1993-07-22 Menetelmä terapeuttisesti käyttökelpoisten indolinyyli-N-hydroksiurea- ja indolinyyli-N-hydroksaamihappojohdannaisten valmistamiseksi

Country Status (24)

Country Link
EP (1) EP0651743B1 (fr)
JP (1) JP2661841B2 (fr)
KR (1) KR950702533A (fr)
CN (1) CN1085894A (fr)
AT (1) ATE161250T1 (fr)
AU (1) AU675654B2 (fr)
BR (1) BR9306762A (fr)
CA (1) CA2140344C (fr)
CZ (1) CZ15995A3 (fr)
DE (1) DE69315841T2 (fr)
DK (1) DK0651743T3 (fr)
ES (1) ES2110101T3 (fr)
FI (1) FI104068B1 (fr)
GR (1) GR3025809T3 (fr)
HU (1) HUT70182A (fr)
IL (1) IL106359A0 (fr)
MX (1) MX9304441A (fr)
NZ (1) NZ253881A (fr)
PL (1) PL307229A1 (fr)
SK (1) SK8695A3 (fr)
TW (1) TW227556B (fr)
WO (1) WO1994002459A1 (fr)
YU (1) YU50893A (fr)
ZA (1) ZA935304B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006573A1 (fr) * 1990-10-02 1992-04-16 Stat-Tech International Corporation Dispositif servant a dissiper et a decharger une charge electrique
AU4400597A (en) * 1996-10-08 1998-05-05 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
US5952322A (en) * 1996-12-05 1999-09-14 Pfizer Inc. Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
AU4653199A (en) * 1998-07-17 2000-02-07 Daiichi Fine Chemical Co., Ltd. Novel remedies for allergic diseases
WO2001087834A1 (fr) * 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Antagoniste de l'hormone de concentration de la melanine
UA95084C2 (en) * 2005-11-04 2011-07-11 Амира Фармасутикалз, Инк. 5-lipoxygenase-activating protein (flap) inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059408T3 (es) * 1987-02-10 1994-11-16 Abbott Lab Un proceso para la preparacion de un compuesto.
PH30133A (en) * 1989-09-07 1997-01-21 Abbott Lab Indole-, benzofuran-, and benzothiophene-containing lipoxygenase inhibiting compounds
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터
US5132319A (en) * 1991-03-28 1992-07-21 Merck Frosst Canada, Inc. 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
JP2661841B2 (ja) 1997-10-08
FI933307A0 (fi) 1993-07-22
KR950702533A (ko) 1995-07-29
JPH0641068A (ja) 1994-02-15
DK0651743T3 (da) 1998-02-02
FI104068B (fi) 1999-11-15
CZ15995A3 (en) 1995-09-13
WO1994002459A1 (fr) 1994-02-03
PL307229A1 (en) 1995-05-15
FI933307A (fi) 1994-01-24
CN1085894A (zh) 1994-04-27
NZ253881A (en) 1996-01-26
ATE161250T1 (de) 1998-01-15
DE69315841D1 (de) 1998-01-29
TW227556B (fr) 1994-08-01
YU50893A (sh) 1996-07-24
GR3025809T3 (en) 1998-03-31
AU675654B2 (en) 1997-02-13
SK8695A3 (en) 1995-07-11
HU9302126D0 (en) 1993-10-28
CA2140344C (fr) 1997-08-26
EP0651743A1 (fr) 1995-05-10
BR9306762A (pt) 1998-12-08
AU4529193A (en) 1994-02-14
EP0651743B1 (fr) 1997-12-17
HUT70182A (en) 1995-09-28
ES2110101T3 (es) 1998-02-01
MX9304441A (es) 1994-07-29
IL106359A0 (en) 1993-11-15
ZA935304B (en) 1995-01-23
DE69315841T2 (de) 1998-04-09
CA2140344A1 (fr) 1994-02-03

Similar Documents

Publication Publication Date Title
IL88122A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing them
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE203524T1 (de) Chinazolin-derivate
MXPA05007496A (es) Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes.
AU2736088A (en) Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
HUT62264A (en) Process for producing amidino compounds and pharmaceutical compositions comprising same as active ingredient
HUT60271A (en) Process for producing tricyclic compounds, functioning as enzyme inhibitior and comprising amino or nitro group and pharmaceutical compositions comprising same as active ingredient
FI104068B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolinyyli-N-hydroksiurea- ja indolinyyli-N-hydroksaamihappojohdannaisten valmistamiseksi
TW222627B (fr)
CA2267800A1 (fr) Composes tricycliques presentant une activite d'inhibiteurs de la ras-fpt
ATE215075T1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
CA2133218A1 (fr) Derives de substitution phenylique de cycloalkylhydroxyuree, agent d'inhibition de la lipoxygenase
GR3019196T3 (en) Tetrahydrobenzazepine derivatives which inhibit lipoxygenase
NO165022C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazol- og imidazolderivater.
GR3018321T3 (en) N-hydroxyurea derivatives which inhibit lipoxygenase.

Legal Events

Date Code Title Description
MA Patent expired